Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-controlled randomised study☆
To access this article, please choose from the options below
☆ Presented at 13th ECCO, held October 30th to November 3rd, 2005, Paris.
PII: S0167-8140(08)00101-1
doi:10.1016/j.radonc.2008.02.007
© 2008 Elsevier Ireland Ltd. All rights reserved.
